Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Crop Infrastructure tenant in Nevada completes harvest of cannabidiol hemp

Samples from 240 acres have been submitted for testing to determine concentrations.
Woman holding marijuana leaf
Samples of the Nevada crop are being tested to determine concentrations

Cannabis company and greenhouse lessor Crop Infrastructure Corp (CSE:CROP, CSE:CROP.CN, OTCMKTS:CRXPF) said Tuesday that a tenant in Nevada has completed the harvest of 240 acres of cannabidiol hemp.

Samples have been submitted for independent testing to determine cannabidiol concentrations.

READ: Crop Infrastructure announces dispensary application moves forward; Hempire's harvest 'looks phenomenal'

The Vancouver-based company added that it has completed site testing at the hemp-cannabidiol project and that soil is ready for 2019 planting.

Once the cannabis certificate of analysis (CoA) has been received, the CBD will be shipped to the company's partner toll processor to produce CBD isolate.

Crop Infrastructure is developing a cannabis-infused line of soft drinks with nutritional content.

Last week, Crop revealed it had hired a firm to build its Nevada facility.

An extraction tech group will build a one-ton-per-day extraction facility at its Nevada CBD farm, the group said.

On October 23 this year, Crop inked its first major supply deal for its Hempire tenant in Nevada with a  commercial extraction technology company.

Namely, a three-year, 500,000-pound-per-year (1.5 million pounds in total) deal with deliveries starting August next year.

Shares of Crop Infrastructure slipped $0.03 to $0.36 at Monday’s close on the Canadian Securities Exchange.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full CROP profile View Profile

Crop Infrastructure Corp. Timeline

Related Articles

1539364967_Cannabis-plant.jpg
October 10 2018
Management behind ICC International Cannabis Corp has a clear buy, build and sell strategy
Laboratory testing
October 09 2018
Fifteen patients have been enrolled in the trial being carried out at Children’s Hospital of Philadelphia in the USA.
cannabis leaf and green tablets
October 29 2018
The company will now proceed with stage II of the human clinical trial.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use